Core Viewpoint - The SLM Corporation, also known as Sallie Mae, is facing a class action lawsuit due to alleged violations of the Securities Exchange Act of 1934, with claims of misleading statements regarding delinquency rates in private education loans [1][3]. Group 1: Class Action Details - Investors in SLM securities from July 25, 2025, to August 14, 2025, can seek appointment as lead plaintiff by February 17, 2026 [1]. - The lawsuit is titled Zappia v. SLM Corporation and is filed in the District of New Jersey [1]. - The allegations include that SLM's executives made false statements about the company's financial health and the effectiveness of its loss mitigation programs [3]. Group 2: Financial Impact - A report from TD Cowen indicated that July 2025 delinquencies increased by 49 basis points month-over-month, which was significantly worse than the expected seasonal increase of 10 basis points [4]. - This report contradicted statements made by SLM's CFO, who claimed delinquency rates were following normal seasonal trends [4]. - Following the release of this report, SLM's stock price dropped by approximately 8% [4]. Group 3: Legal Process - The Private Securities Litigation Reform Act of 1995 allows any investor who suffered losses during the class period to seek lead plaintiff status [5]. - The lead plaintiff will represent the interests of all class members and can choose a law firm for litigation [5]. - Participation as a lead plaintiff does not affect an investor's ability to share in any potential recovery [5]. Group 4: Firm Background - Robbins Geller Rudman & Dowd LLP is a leading law firm specializing in securities fraud and shareholder litigation, having recovered over $2.5 billion for investors in 2024 alone [6]. - The firm has been ranked 1 in securing monetary relief for investors in securities class action cases for four out of the last five years [6]. - Robbins Geller has a significant history of obtaining large recoveries in securities class action lawsuits, including the largest recovery of $7.2 billion in the Enron case [6].